Prevalence and risk factors of low anterior resection syndrome: Meta-analysis with Subgroup Analysis

##plugins.themes.academic_pro.article.sidebar##

Published May 24, 2026
https://doi.org/10.62438/tunismed.v104i05.6646
Download
PDF
Vol. 104 No. 05 (2026): Tunis Med May 2026

##plugins.themes.academic_pro.article.main##

Mohamed Mehdi Trabelsi
Department B of Surgery - Charles Nicolle hospital. Faculty of medicine of Tunis. University of Tunis El Manar, Tunisia
Neirouz Kammoun
Department B of Surgery - Charles Nicolle hospital. Faculty of medicine of Tunis. University of Tunis El Manar, Tunisia
Salsabil Nasri
Department B of Surgery - Charles Nicolle hospital. Faculty of medicine of Tunis. University of Tunis El Manar, Tunisia
Amine Ben Safta
Department B of Surgery - Charles Nicolle hospital. Faculty of medicine of Tunis. University of Tunis El Manar, Tunisia
Imen Samaali
Department B of Surgery - Charles Nicolle hospital. Faculty of medicine of Tunis. University of Tunis El Manar, Tunisia
Ramzi Nouira
Department B of Surgery - Charles Nicolle hospital. Faculty of medicine of Tunis. University of Tunis El Manar, Tunisia
Chadli Dziri
Department B of Surgery - Charles Nicolle hospital. Faculty of medicine of Tunis. University of Tunis El Manar, Tunisia

Abstract

Background: The prevalence of major LARS and its associated risk factors remains variably reported in the literature. This meta-analysis aimed to assess the pooled prevalence of major LARS and to identify its predictive factors.
Methods: We conducted a meta-analysis in accordance with PRISMA 2020 and AMSTAR 2 guidelines to identify studies reporting the prevalence of major LARS or its associated risk factors. Subgroup analyses was used to explain heterogeneity.
Results: A total of 21 studies comprising 3,730 patients were included. The pooled prevalence of major LARS was 36.8% (95% CI: 30.1%–44.0%), with a 95% prediction interval of 12.0%–71.2%, indicating substantial heterogeneity. Tumor location < 5 cm from the anal margin (p < 0.001) and neoadjuvant radiochemotherapy (p = 0.006) were significantly associated with increased major LARS risk. No significant associations were found with anastomotic leakage, surgical approach, or stoma closure timing.
Conclusion: Our meta-analysis showed a prevalence comparable to previously published data. Low tumor location and neoadjuvant radiochemotherapy were identified as two independent risk factors for major LARS. Prospective randomized trials are necessary to improve risk stratification for the development of major LARS.

Keywords:

low anterior resection syndrome, rectal cancer, prevalence, risk factors, meta-analysis

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

  1. Troester AM, Gaertner WB. Contemporary management of rectal cancer. Surg Open Sci. 2024;18:17-22. DOI: 10.1016/j.
  2. sopen.2024.01.009
  3. Heald RJ, Husband EM, Ryall RDH. The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? J Br Surg. 1 oct
  4. ;69(10):613-6.
  5. Bryant CL, Lunniss PJ, Knowles CH, Thaha MA, Chan CL. Anterior resection syndrome. Lancet Oncol. 2012;13(9):e403-8.
  6. Emmertsen KJ, Laurberg S. Low Anterior Resection Syndrome Score: Development and Validation of a Symptom-Based Scoring
  7. System for Bowel Dysfunction After Low Anterior Resection for Rectal Cancer. Ann Surg. 2012;255(5):922-8.
  8. Keane C, Fearnhead NS, Bordeianou L, Christensen P, Espin Basany E, Laurberg S, et al. International consensus definition of low
  9. anterior resection syndrome. Colorectal Dis. 2020;22(3):331-41.
  10. Croese AD, Lonie JM, Trollope AF, Vangaveti VN, Ho YH. A meta-analysis of the prevalence of Low Anterior Resection Syndrome and
  11. systematic review of risk factors. Int J Surg. 2018;56:234-41.
  12. Sun R, Dai Z, Zhang Y, Lu J, Zhang Y, Xiao Y. The incidence and risk factors of low anterior resection syndrome (LARS) after sphincter-
  13. preserving surgery of rectal cancer: a systematic review and meta-analysis. Support Care Cancer. 2021;29(12):7249-58.
  14. Ye L, Huang M, Huang Y, Yu K, Wang X. Risk factors of postoperative low anterior resection syndrome for colorectal cancer: A meta-
  15. analysis. Asian J Surg.2022;45(1):39-50.
  16. Xu LL, Cheng TC, Xiang NJ, Chen P, Jiang ZW, Liu XX. Risk factors for severe low anterior resection syndrome in patients with rectal cancer undergoing sphincter-preserving resection: A systematic review and meta-analysis. Oncol Lett. 2023;27(1):30.
  17. Pape E, Pattyn P, Van Hecke A, Somers N, Van De Putte D, Ceelen W, et al. Impact of low anterior resection syndrome (LARS) on the
  18. quality of life and treatment options of LARS – A cross sectional study. Eur J Oncol Nurs. 2021;50:101878.
  19. Pieniowski EHA, Palmer GJ, Juul T, Lagergren P, Johar A, Emmertsen KJ, et al. Low Anterior Resection Syndrome and Quality of Life After
  20. Sphincter-Sparing Rectal Cancer Surgery: A Long-term Longitudinal Follow-up. Dis Colon Rectum. 2019;62(1):14-20.
  21. University of Oxford, Centre for Evidence-Based Medicine. Oxford Centre for Evidence-Based Medicine: Levels of Evidence (March
  22. . 2009
  23. Schünemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, et al. Grading quality of evidence and strength of recommendations
  24. for diagnostic tests and strategies. BMJ. 2008;336(7653):1106-10.
  25. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for
  26. reporting systematic reviews. BMJ. 2021;372: n71.
  27. Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that
  28. include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358: j4008.
  29. Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies ( MINORS ):
  30. development and validation of a new instrument. ANZ J Surg. 2003;73(9):712-6.
  31. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res
  32. Methodol. 2005;5(1):13.
  33. Dziri C, Fingerhut A. Up-to-date composition and critical appraisal of meta-analyses of comparative studies. Ann Laparosc Endosc
  34. Surg. 2025;10:4.
  35. Borenstein M, éditeur. Introduction to meta-analysis. Chichester, U.K: John Wiley & Sons; 2009. 421 p.
  36. Borenstein M. Comprehensive Meta-Analysis Software. In: Egger M, Higgins JPT, Davey Smith G, editors. Systematic Reviews in
  37. Health Research. 1st ed. Wiley; 2022. p. 535-48.
  38. Al-Saidi AMA, Verkuijl SJ, Hofker S, Trzpis M, Broens PMA. How Should the Low Anterior Resection Syndrome Score Be Interpreted?
  39. Dis Colon Rectum. avr 2020;63(4):520-6.
  40. Dulskas A, Kavaliauskas P, Kulikauskas E, Smolskas E, Pumputiene K, Samalavicius NE, et al. Low Anterior Resection Syndrome:
  41. What Have We Learned Assessing a Large Population? J Clin Med. 2022;11(16):4752.
  42. Van Heinsbergen M, Van Der Heijden JAG, Stassen LP, Melenhorst J, De Witte E, Belgers EH, et al. The low anterior resection syndrome
  43. in a reference population: prevalence and predictive factors in the Netherlands. Colorectal Dis. 2020;22(1):46-52.
  44. Juul T, Elfeki H, Christensen P, Laurberg S, Emmertsen KJ, Bager P. Normative Data for the Low Anterior Resection Syndrome Score
  45. (LARS Score). Ann Surg. juin 2019;269(6):1124-8.
  46. Lim SL, Wan Zain WZ, Zahari Z, Zakaria AD, Hashim MNM, Wong MPK, et al. Risk factors associated with low anterior resection
  47. syndrome: a cross-sectional study. Ann Coloproctology. 31 oct 2023;39(5):427-34.
  48. Croese AD, Zubair ON, Lonie J, Trollope AF, Vangaveti VN, Mushaya C, et al. Prevalence of low anterior resection syndrome at a regional
  49. Australian centre. ANZ J Surg 2018;88(12).
  50. Benli ̇ S, Çolak T, Türkmenoğlu MÖ. Factors influencing anterior/low anterior resection syndrome after rectal or sigmoid resections. Turk
  51. J Med Sci. 30 avr 2021;51(2):623-30.
  52. Homma Y, Mimura T, Koinuma K, Horie H, Lefor AK, Sata N. Low anterior resection syndrome: Incidence and association with
  53. quality of life. Ann Gastroenterol Surg. 2024;8(1):114-23.
  54. Nicotera A, Falletto E, Arezzo A, Mistrangelo M, Passera R, Morino M. Risk factors for Low Anterior Resection Syndrome (LARS) in
  55. patients undergoing laparoscopic surgery for rectal cancer. Surg Endosc. 2022;36(8):6059-66.
  56. K C, Jacob AT, Muralee M, Sudham MW, L M, Balakrishnan S. Low anterior resection syndrome and quality of life of patients after
  57. sphincter preservation surgery: A prospective study. Cureus. 2024.
  58. Jin DA, Gu FP, Meng TL, Zhang XX. Effect of low anterior resection syndrome on quality of life in colorectal cancer patients: A
  59. retrospective observational study. World J Gastrointest Surg. 27 2023;15(10):2123-32.
  60. Ekkarat P, Boonpipattanapong T, Tantiphlachiva K, Sangkhathat S. Factors determining low anterior resection syndrome after
  61. rectal cancer resection: A study in Thai patients. Asian J Surg. 2016;39(4):225-31.
  62. On behalf of the LARRIS Trial Management Group, Hughes DL, Cornish J, Morris C. Functional outcome following rectal surgery—
  63. predisposing factors for low anterior resection syndrome. Int J Colorectal Dis. 2017;32(5):691-7.
  64. Dulskas A, Kavaliauskas P, Pilipavicius L, Jodinskas M, Mikalonis M, Samalavicius NE. Long-term bowel dysfunction following low
  65. anterior resection. Sci Rep. 17 juill 2020;10(1):11882.
  66. Pieniowski EHA, Nordenvall C, Palmer G, Johar A, Tumlin Ekelund S, Lagergren P, et al. Prevalence of low anterior resection syndrome
  67. and impact on quality of life after rectal cancer surgery: population- based study. BJS Open. 1 oct 2020;4(5):935-42.
  68. Ihnát P, Vávra P, Prokop J, Pelikán A, Ihnát Rudinská L, Penka I. Functional outcome of low rectal resection evaluated by anorectal manometry. ANZ J Surg 2018;88(6).
  69. Qin Q, Huang B, CaoW, Zhou J, MaT, Zhou Z, et al. Bowel Dysfunction After LowAnterior ResectionWithNeoadjuvantChemoradiotherapy
  70. or Chemotherapy Alone for Rectal Cancer: A Cross-Sectional Study from China. Dis Colon Rectum. 2017;60(7):697-705.
  71. Ribas Y, Aguilar F, Jovell-Fernández E, Cayetano L, Navarro-Luna A, Muñoz-Duyos A. Clinical application of the LARS score: results from
  72. a pilot study. Int J Colorectal Dis. 2017;32(3):409-18.
  73. Su J, Liu Q, Zhou D, Yang X, Jia G, Huang L, et al. The status of low anterior resection syndrome: data from a single-center in China.
  74. BMC Surg. 2023;23(1):110.
  75. Ri H, Kang H, Xu Z, Kim K, Ren Y, Gong Z, et al. The risk factors of low anterior resection syndrome after colorectal cancer surgery: A
  76. retrospective study of 566 patients in a single institution in China. Front Surg. 2022;9:990702.
  77. Jimenez-Gomez LM, Espin-Basany E, Trenti L, Martí-Gallostra M, Sánchez-García JL, Vallribera-Valls F, et al. Factors associated with
  78. low anterior resection syndrome after surgical treatment of rectal cancer. Colorectal Dis. 2018;20(3):195-200.
  79. Kim MJ, Park JW, Lee MA, Lim HK, Kwon YH, Ryoo SB, et al. Two dominant patterns of low anterior resection syndrome and their
  80. effects on patients’ quality of life. Sci Rep. 2021;11(1):3538.
  81. Huu Phu L, Tat Bang H, Viet Binh N, Danh Tan H, Van Viet U, Tin NT. Major low anterior resection syndrome (LARS) and quality of life in
  82. patients with low rectal cancer: A preoperative survey using LARS score and EORTC QLQ-C30. Cureus. 2023.
  83. Trabelsi MM, Samaali I, Kammoun N, Ben Safta A, Oueslati A, Dougaz W, et al. Predictive factors of major low anterior resection
  84. syndrome after surgery for rectal tumors. Tunis Med. 2024;102(10).
  85. Carrillo A, Enríquez-Navascués JM, Rodríguez A, Placer C, Múgica JA, Saralegui Y, et al. Incidencia y caracterización del síndrome de
  86. resección anterior de recto mediante la utilización de la escala LARS (low anterior resection score). Cir Esp. 2016;94(3):137-43.
  87. Borenstein M, Higgins JPT, Hedges LV, Rothstein HR. Basics of meta- analysis: I2 is not an absolute measure of heterogeneity. Res Synth
  88. Methods. 2017;8(1):5-18.
  89. Kim S, Kang SI, Kim SH, Kim JH. The Effect of Anastomotic Leakage on the Incidence and Severity of Low Anterior Resection Syndrome
  90. in Patients Undergoing Proctectomy: A Propensity Score Matching Analysis. Ann Coloproctology. 2021;37(5):281-90.
  91. Arias F, Eito C, Asín G, Mora I, Cambra K, Mañeru F, et al. Fecal incontinence and radiation dose on anal sphincter in patients with
  92. locally advanced rectal cancer (LARC) treated with preoperative chemoradiotherapy: a retrospective, single-institutional study. Clin
  93. Transl Oncol. 2017;19(8):969-75.
  94. Lee WY, Takahashi T, Pappas T, Mantyh CR, Ludwig KA. Surgical autonomic denervation results in altered colonic motility: an
  95. explanation for low anterior resection syndrome? Surgery.2008;143(6):778-83.
  96. Hain E, Manceau G, Maggiori L, Mongin C, Prost À La Denise J, Panis Y. Bowel dysfunction after anastomotic leakage in laparoscopic
  97. sphincter-saving operative intervention for rectal cancer: A case- matched study in 46 patients using the Low Anterior Resection
  98. Score. Surgery. 2017;161(4):1028-39.
  99. Vogel I, Reeves N, Tanis PJ, Bemelman WA, Torkington J, Hompes R, et al. Impact of a defunctioning ileostomy and time to stoma closure
  100. on bowel function after low anterior resection for rectal cancer: a systematic review and meta-analysis. Tech Coloproctology.
  101. ;25(7):751-60.
  102. Dulskas A, Miliauskas P, Tikuisis R, Escalante R, Samalavicius NE. The functional results of radical rectal cancer surgery: review of the
  103. literature. Acta Chir Belg. 2016;116(1):1-10